TCM

TCG Crossover Management Portfolio holdings

AUM $876M
1-Year Est. Return 23.66%
This Quarter Est. Return
1 Year Est. Return
+23.66%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$567M
AUM Growth
+$233M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
26
New
Increased
Reduced
Closed

Top Buys

1
+$74.9M
2
+$27M
3
+$25.8M
4
KALV icon
KalVista Pharmaceuticals
KALV
+$23M
5
VECT
VectivBio Holding AG Ordinary Shares
VECT
+$20.2M

Top Sells

1
+$10.1M
2
+$9.13M
3
+$5.27M
4
TNGX icon
Tango Therapeutics
TNGX
+$4.24M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$3M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$110M 19.43%
5,141,118
+1,263,215
2
$83.6M 14.76%
288,054
+258,054
3
$42M 7.41%
3,631,042
+150,000
4
$37M 6.53%
5,905,400
5
$36.8M 6.49%
15,187,073
+3,071,147
6
$32.1M 5.67%
2,104,875
7
$31.7M 5.59%
30,894
+3,478
8
$28.7M 5.07%
983,610
-180,390
9
$25.8M 4.56%
+787,231
10
$23M 4.05%
+3,395,495
11
$20.2M 3.57%
+2,333,300
12
$18M 3.18%
1,144,939
13
$17.7M 3.12%
1,423,642
+75,000
14
$15.2M 2.68%
+854,853
15
$15.1M 2.67%
1,989,103
+1,043,396
16
$10.5M 1.85%
1,000,000
17
$7.91M 1.4%
584,955
-57,234
18
$4.64M 0.82%
300,000
19
$4.5M 0.79%
+486,795
20
$1.86M 0.33%
253,069
-1,500
21
$274K 0.05%
288,390
-266,610
22
– –
-1,643,500
23
– –
-132,758
24
– –
-1,172,250
25
– –
-72,777
1
2